Skip to main content

Table 5 EQ-5D index scores following first 8% capsaicin patch treatment

From: Effectiveness of the capsaicin 8% patch in the management of peripheral neuropathic pain in European clinical practice: the ASCEND study

EQ-5D index score Responders at Weeks 2 and 8 Non-responders at Weeks 2 and 8 Overall
  ≥30%a ≥50%a <30%a <50%a  
Baseline, mean (SD) 0.392 (0.352)
n = 182
0.386 (0.367)
n = 108
0.306 (0.349)
n = 229
0.329 (0.347)
n = 303
0.345 (0.354)
n = 419
Change from baseline, mean (SD)
 Week 2 0.292 (0.313)
n = 176
0.337 (0.327)
n = 104
0.128 (0.297)
n = 223
0.152 (0.296)
n = 295
0.199 (0.315)
n = 400
 Week 8 0.323 (0.307)
n = 165
0.349 (0.321)
n = 99
0.104 (0.323)
n = 209
0.147 (0.322)
n = 275
0.200 (0.333)
n = 375
 Week 12 0.289 (0.352)
n = 165
0.342 (0.359)
n = 97
0.111 (0.320)
n = 196
0.138 (0.325)
n = 264
0.190 (0.348)
n = 363
 Week 26 0.288 (0.292)
n = 93
0.309 (0.290)
n = 62
0.099 (0.339)
n = 112
0.131 (0.334)
n = 143
0.185 (0.330)
n = 206
 Week 39 0.306 (0.320)
n = 78
0.310 (0.321)
n = 52
0.123 (0.335)
n = 96
0.161 (0.339)
n = 122
0.205 (0.340)
n = 174
 Week 52 0.307 (0.327)
n = 76
0.305 (0.330)
n = 52
0.114 (0.376)
n = 100
0.153 (0.373)
n = 124
0.198 (0.367)
n = 176
  1. aPercentage reduction in average NPRS score. EQ-5D, EuroQol 5 Dimension 3-level; SD, standard deviation